13-32336266-T-C

Variant summary

Our verdict is Benign. The variant received -11 ACMG points: 0P and 11B. BP4_ModerateBP6_Very_StrongBP7

The NM_000059.4(BRCA2):​c.1911T>C​(p.Gly637Gly) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000174 in 1,601,302 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★★). Synonymous variant affecting the same amino acid position (i.e. G637G) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0010 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000084 ( 0 hom. )

Consequence

BRCA2
NM_000059.4 splice_region, synonymous

Scores

2
Splicing: ADA: 0.01075
2

Clinical Significance

Benign reviewed by expert panel B:20

Conservation

PhyloP100: 1.88

Publications

5 publications found
Variant links:
Genes affected
BRCA2 (HGNC:1101): (BRCA2 DNA repair associated) Inherited mutations in BRCA1 and this gene, BRCA2, confer increased lifetime risk of developing breast or ovarian cancer. Both BRCA1 and BRCA2 are involved in maintenance of genome stability, specifically the homologous recombination pathway for double-strand DNA repair. The largest exon in both genes is exon 11, which harbors the most important and frequent mutations in breast cancer patients. The BRCA2 gene was found on chromosome 13q12.3 in human. The BRCA2 protein contains several copies of a 70 aa motif called the BRC motif, and these motifs mediate binding to the RAD51 recombinase which functions in DNA repair. BRCA2 is considered a tumor suppressor gene, as tumors with BRCA2 mutations generally exhibit loss of heterozygosity (LOH) of the wild-type allele. [provided by RefSeq, May 2020]
BRCA2 Gene-Disease associations (from GenCC):
  • BRCA2-related cancer predisposition
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • breast-ovarian cancer, familial, susceptibility to, 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Fanconi anemia complementation group D1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • pancreatic cancer, susceptibility to, 2
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • sarcoma
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • medulloblastoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -11 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.42).
BP6
Variant 13-32336266-T-C is Benign according to our data. Variant chr13-32336266-T-C is described in ClinVar as Benign. ClinVar VariationId is 136554.Status of the report is reviewed_by_expert_panel, 3 stars.
BP7
Synonymous conserved (PhyloP=1.88 with no splicing effect.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000059.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA2
NM_000059.4
MANE Select
c.1911T>Cp.Gly637Gly
splice_region synonymous
Exon 11 of 27NP_000050.3A0A7P0T9D7
BRCA2
NM_001432077.1
c.1911T>Cp.Gly637Gly
splice_region synonymous
Exon 11 of 27NP_001419006.1A0A7P0T9D7
BRCA2
NM_001406720.1
c.1911T>Cp.Gly637Gly
splice_region synonymous
Exon 11 of 27NP_001393649.1A0A8V8TPZ2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA2
ENST00000380152.8
TSL:5 MANE Select
c.1911T>Cp.Gly637Gly
splice_region synonymous
Exon 11 of 27ENSP00000369497.3P51587
BRCA2
ENST00000544455.6
TSL:1
c.1911T>Cp.Gly637Gly
splice_region synonymous
Exon 11 of 27ENSP00000439902.1P51587
BRCA2
ENST00000530893.7
TSL:1
c.1542T>Cp.Gly514Gly
splice_region synonymous
Exon 11 of 27ENSP00000499438.2A0A590UJI7

Frequencies

GnomAD3 genomes
AF:
0.00103
AC:
156
AN:
152158
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000279
AC:
67
AN:
240050
AF XY:
0.000223
show subpopulations
Gnomad AFR exome
AF:
0.00396
Gnomad AMR exome
AF:
0.0000944
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000907
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000842
AC:
122
AN:
1449026
Hom.:
0
Cov.:
32
AF XY:
0.0000597
AC XY:
43
AN XY:
720454
show subpopulations
African (AFR)
AF:
0.00312
AC:
102
AN:
32728
American (AMR)
AF:
0.0000958
AC:
4
AN:
41768
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25436
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39608
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83620
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53138
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5136
European-Non Finnish (NFE)
AF:
0.00000361
AC:
4
AN:
1107824
Other (OTH)
AF:
0.000201
AC:
12
AN:
59768
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.456
Heterozygous variant carriers
0
7
15
22
30
37
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00103
AC:
157
AN:
152276
Hom.:
0
Cov.:
32
AF XY:
0.00106
AC XY:
79
AN XY:
74470
show subpopulations
African (AFR)
AF:
0.00363
AC:
151
AN:
41552
American (AMR)
AF:
0.000392
AC:
6
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68016
Other (OTH)
AF:
0.00
AC:
0
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
9
18
26
35
44
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000394
Hom.:
0
Bravo
AF:
0.00109
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (7)
-
-
3
Breast-ovarian cancer, familial, susceptibility to, 2 (3)
-
-
3
Hereditary breast ovarian cancer syndrome (3)
-
-
3
Hereditary cancer-predisposing syndrome (3)
-
-
2
not provided (2)
-
-
1
Familial cancer of breast (1)
-
-
1
Malignant tumor of breast (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.42
CADD
Benign
13
DANN
Benign
0.84
PhyloP100
1.9
Mutation Taster
=47/53
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.011
dbscSNV1_RF
Benign
0.098
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11571652; hg19: chr13-32910403; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.